Tags

Type your tag names separated by a space and hit enter

[Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast].
Ned Tijdschr Geneeskd. 1997 Feb 22; 141(8):368-72.NT

Abstract

Oestrogen replacement therapy (ORT) significantly increases the relative risk (RR) of endometrial cancer, especially long-term oestrogen use (RR: 9.5; 95% confidence interval (CI): 7.4-12.3). Addition of a progestin to ORT reduces this increased risk completely or largely. The risk of breast cancer is increased after ORT of 5 years or longer (RR: 1.23; 95% CI: 1.08-1.40). Addition of a progestin does not reduce this increased risk. The possibility cannot be excluded that long-term ORT increases the risk of epithelial ovarian cancer. No significant association between ORT and cervical cancer has been demonstrated. It is safe to prescribe ORT for a period shorter than 5 years for women with menopausal symptoms. Addition of a progestin is indicated when the uterus is in situ. Hormonal supplementation therapy is to be discouraged in women treated for breast cancer, may be considered in young women previously treated for endometrial or ovarian cancer with a good prognosis and severe menopausal symptoms and is justified in women previously treated for cervical cancer.

Authors+Show Affiliations

Academisch Ziekenhuis, afd. Verloskunde en Gynaecologie, Amsterdam.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

dut

PubMed ID

9157296

Citation

Burger, C W., et al. "[Postmenopausal Hormone Replacement Therapy and Cancer of the Female Genitalia and Breast]." Nederlands Tijdschrift Voor Geneeskunde, vol. 141, no. 8, 1997, pp. 368-72.
Burger CW, Koomen I, Peters NA, et al. [Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast]. Ned Tijdschr Geneeskd. 1997;141(8):368-72.
Burger, C. W., Koomen, I., Peters, N. A., van Leeuwen, F. E., & Kenemans, P. (1997). [Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast]. Nederlands Tijdschrift Voor Geneeskunde, 141(8), 368-72.
Burger CW, et al. [Postmenopausal Hormone Replacement Therapy and Cancer of the Female Genitalia and Breast]. Ned Tijdschr Geneeskd. 1997 Feb 22;141(8):368-72. PubMed PMID: 9157296.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast]. AU - Burger,C W, AU - Koomen,I, AU - Peters,N A, AU - van Leeuwen,F E, AU - Kenemans,P, PY - 1997/2/22/pubmed PY - 1997/2/22/medline PY - 1997/2/22/entrez SP - 368 EP - 72 JF - Nederlands tijdschrift voor geneeskunde JO - Ned Tijdschr Geneeskd VL - 141 IS - 8 N2 - Oestrogen replacement therapy (ORT) significantly increases the relative risk (RR) of endometrial cancer, especially long-term oestrogen use (RR: 9.5; 95% confidence interval (CI): 7.4-12.3). Addition of a progestin to ORT reduces this increased risk completely or largely. The risk of breast cancer is increased after ORT of 5 years or longer (RR: 1.23; 95% CI: 1.08-1.40). Addition of a progestin does not reduce this increased risk. The possibility cannot be excluded that long-term ORT increases the risk of epithelial ovarian cancer. No significant association between ORT and cervical cancer has been demonstrated. It is safe to prescribe ORT for a period shorter than 5 years for women with menopausal symptoms. Addition of a progestin is indicated when the uterus is in situ. Hormonal supplementation therapy is to be discouraged in women treated for breast cancer, may be considered in young women previously treated for endometrial or ovarian cancer with a good prognosis and severe menopausal symptoms and is justified in women previously treated for cervical cancer. SN - 0028-2162 UR - https://www.unboundmedicine.com/medline/citation/9157296/[Postmenopausal_hormone_replacement_therapy_and_cancer_of_the_female_genitalia_and_breast]_ L2 - http://www.diseaseinfosearch.org/result/960 DB - PRIME DP - Unbound Medicine ER -